<i>DNMT3A</i> Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous LeukemiaAlison R. Sehgal, Martin Carroll, Phyllis A. Gimotty et al.|Clinical Cancer Research|2015Cited by 55
Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in GlioblastomaMacLean P. Nasrallah, Jennifer J.D. Morrissette, Zev A. Binder et al.|Academic Pathology|2019Cited by 31
Genotypic and clinical heterogeneity within NCCN favorable-risk acute myeloid leukemiaStephen A. Strickland, Adam C. Seegmiller, Aaron C. Shaver et al.|Leukemia Research|2018Cited by 21
A novel approach for next‐generation sequencing of circulating tumor cellsStephanie S. Yee, Erica L. Carpenter, David Lieberman et al.|Molecular Genetics & Genomic Medicine|2016Cited by 21
A Modified Integrated Genetic Model for Risk Prediction in Younger Patients with Acute Myeloid LeukemiaCaroline E. Sloan, Martin Carroll, Marlise R. Luskin et al.|PLoS ONE|2016Cited by 10